NSI-189 phosphate freebase

  • NSI-189 Phosphate Freebase /NSI 189 Phosphate Base

    NSI-189 is neurogenic and nootropic research agent that was developed from nicotinamide and pyrazine. Randomized controlled trials have shown that it stimulates neurogenesis or neuronal cell production in the brain. In animal studies, it has also been shown to increase the volume of hippocampus by 20% thereby reversing behavioral symptoms of depression. Such studies have shown that it may be an effective treatment for depression. It is also thought to be a promising treatment for other condition including post-traumatic stress disorder (PTSD), Alzheimer’s disease and age-related cognitive problems. NSI-189 is an experimental antidepressant. Neuralstem, Inc. is currently testing it for use in major depression, in addition to treating cognitive impairments, and brain degeneration. It may induce specific brain regeneration. NSI-189 is most likely selective only to two nervous system controlling regions in the brain (hippocampus, subventricular zone)

    Email Details
Get the latest price? We'll respond as soon as possible(within 12 hours)